Brief: Ozempic-Maker Novo Open To Upgrading Us Listing - Ft
BRIEF-Ozempic-Maker Novo Open To Upgrading Us Listing - Ft Sept 23 (Reuters) -
OZEMPIC-MAKER NOVO OPEN TO UPGRADING US LISTING - FT
NOVO IS OPEN TO IDEA OF UPGRADING ITS NEW YORK LISTING AS PART OF EFFORTS TO BOOST THE DANISH WEIGHT-LOSS DRUGMAKER’S PROFILE IN THE US - FT
Source text: https://tinyurl.com/3f6ewddh
Further company coverage: [NOVOb.CO]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Novo Nordisk A/S
See all newsFocus: Beauty giants target 'Ozempic face' as boom in obesity drugs opens new market
Factbox: Anthropic's public benefit fund and how it compares with other big philanthropic efforts
Novo's CagriSema helped women lose 25% of weight on average, analysis shows
As weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Factbox: Major drugmakers turn to China for licensing deals